Art. 16 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 21×
1.

Homeopathic medicinal products other than those referred to in Article 14(1) shall be authorized and labelled in accordance with Articles 8, 10, 10a, 10b, 10c and 11.

2.

A Member State may introduce or retain in its territory specific rules for the preclinical tests and clinical trials of homeopathic medicinal products other than those referred to in Article 14(1) in accordance with the principles and characteristics of homeopathy as practised in that Member State.

In this case, the Member State concerned shall notify the Commission of the specific rules in force.

3.

Title IX shall apply to homeopathic medicinal products, with the exception of those referred to in Article 14(1).

The 10 that are cited most themselves, of 21.

  • Decision_act (EU) 2008/911Law

    … 67.], and in particular Article 16(f) thereof, Having regard to the opinions of the European Medicines Agency, formulated on 7 September 2007 by the Committee for Herbal Medicinal Products, Whereas:

  • Directive (EU) 2004/27Lawamends

  • Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…9Lawamends

    Články 7 a 8 se nepoužijí na přípravky registrované podle článků 10, 10a, 13 až 16 nebo 16a až 16i směrnice 2001/83/ES.

  • Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecision

    However, it is apparent from Articles 13 to 16 of Directive 2001/83, which form part of Chapter 2 of that directive, entitled ‘Specific provisions applicable to homeopathic medicinal products’, in turn contained in Title III of that …

    23 Apr 2020 · 62019CJ0101

  • Gesetz über den Verkehr mit Arzneimitteln2525bLaw

    … auf Arzneimittel, die nach einer homöopathischen Verfahrenstechnik hergestellt werden, sofern diese Arzneimittel dem Artikel 16 Abs. 2 der Richtlinie 2001/83/EG unterliegen. (6) Vor der Entscheidung über die Zulassung eines …

  • Decision_act (EU) 2010/30Law

    … 67.], και ιδίως το άρθρο 16 στοιχείο στ), τις γνώμες του Ευρωπαϊκού Οργανισμού Φαρμάκων, που διατυπώθηκαν την 10η Ιανουαρίου 2008 και την …

  • Decision_act (EU) 2010/28Law

    … 67.], και ιδίως το άρθρο 16 στοιχείο στ), τις γνώμες του Ευρωπαϊκού Οργανισμού Φαρμάκων που διατυπώθηκαν τη 10η Ιανουαρίου 2008 και την 6η …

  • Decision_act (EU) 2010/180Law

    … 67.], y, en particular, su artículo 16, letra f), Visto el dictamen de la Agencia Europea de Medicamentos, formulado el 6 de noviembre de 2008 por el Comité de medicamentos a base de plantas, Considerando lo siguiente:

  • Decision_act (EU) 2012/68Law

    … 67.], y, en particular, su artículo 16 séptimo, Visto el dictamen de la Agencia Europea de Medicamentos, formulado el 15 de julio de 2010 por el Comité de medicamentos a base de plantas, Considerando lo siguiente:

  • Opinion of Mr Advocate General Bot delivered on 24 May 2007. Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische GDecision

    Thus, Article 16(1) of Directive 2001/83 provides that ‘[hjomeopathic medicinal products other than those referred to in Article 14(1) shall be authorised and labelled in accordance with Articles 8, 10, 10a, 10b, 10c and 11 [of the …

    24 May 2007 · 62006CC0084